Remove 2018 Remove Government Remove Hospital Remove Provider
article thumbnail

An Additional Physician from Leading Sarasota Cardiology Practice to Now Offer the Hybrid Choice™ Concierge Program from Concierge Choice Physicians

Concierge Choice Physicians

The physician continues to accept insurance and government programs, as before. They receive enhanced support and service from staff members, and medical advocacy and coordination with other health providers the patient may see. The patient decides what’s right for them. For more information, please visit www.ccpmd.com.

article thumbnail

‘Gas Station Heroin’ Spurs Spike in Poison Control Calls, FDA Warns

Physician's Weekly

Tianeptine is sold in a number of countries as a government-approved treatment for depression. The FDA sent a warning letter to the maker of a product called Tianna in 2018. It claimed to provide “an unparalleled solution to cravings for opiates.” Between 2018 and 2023, tianeptine-related calls to U.S.

Medical 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Supreme Court Finds CMS’ Reduction of Medicare Hospital Outpatient Payment Rates for 340B Hospitals was Not Authorized by Statute

FDA Law

Kirschenbaum — In 2017, the Centers for Medicare & Medicaid Services (“CMS”) issued a final rule to significantly decrease the rate the government will reimburse 340B hospitals in 2018 for outpatient prescription drugs from average sales price (“ASP”) plus 6% to ASP minus 22.5%. By Faraz Siddiqui & Alan M. 52494 (Nov.

article thumbnail

Approaches for Quelling Stigma related to COVID-19

BMJ

8 For example, prestigious medical schools and hospitals could use official WeChat accounts to share information and news with the general public. 8 For example, prestigious medical schools and hospitals could use official WeChat accounts to share information and news with the general public. Doctorate [dissertation].

article thumbnail

The 340B Showdown: HRSA Proceeds Towards Enforcement Despite Litigation

FDA Law

The 340B program, authorized under Section 340B of the Public Health Services Act and administered by HRSA, imposes a ceiling price on pharmaceutical manufacturer sales to “covered entities,” which are certain health clinics that receive federal funding and certain types of safety net hospitals to provide them drugs at lower prices.

article thumbnail

District Court Interprets EKRA

FDA Law

Wasserstein — “EKRA” refers to the Eliminating Kickbacks in Recovery Act, which was part of the Substance Use – Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018. His job was governed by an employment contract that contained both salary provisions and restrictive covenants.

article thumbnail

District Court Interprets EKRA

FDA Law

Wasserstein — “EKRA” refers to the Eliminating Kickbacks in Recovery Act, which was part of the Substance Use – Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018. His job was governed by an employment contract that contained both salary provisions and restrictive covenants.